AMST Amesite

Amesite Inc. (Nasdaq: AMST) Presenting at The Microcap Conference on January 29

Amesite Inc. (Nasdaq: AMST) Presenting at The Microcap Conference on January 29

CEO to Provide Update on Company’s NurseMagic™ App

DETROIT, Jan. 29, 2025 (GLOBE NEWSWIRE) -- (Nasdaq:AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, is pleased to announce its participation in , the premier event for growth-focused companies and investors. The conference is taking place January 28-30, 2025, at the Borgata Hotel Spa & Casino in Atlantic City, NJ.

Amesite’s CEO, Dr. Ann Marie Sastry, will deliver a corporate presentation at 2:30 PM ET today, January 29, and engage in one-on-one meetings with institutional and individual investors to discuss the company’s recent developments with its ™ app, growth strategy, and monetization in B2C and B2B pathways.

NurseMagic™ is an AI-powered mobile application designed to assist nursing professionals and home health care workers by streamlining various aspects of their daily tasks. Developed by Amesite Inc., the app offers a suite of tools aimed at enhancing efficiency, improving patient communication, and supporting career development.

About Amesite Inc.

Amesite Inc. (Nasdaq: AMST) is a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions. Leveraging its proprietary AI infrastructure, Amesite offers cutting-edge applications that cater to both individual and professional needs. NurseMagic™, the company’s mobile app for health and care professionals, streamlines creation of nursing notes and documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace situations.

Forward-Looking Statements

This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company, the Company's planned online machine learning platform, the Company's business plans, any future commercialization of the Company's online learning solutions, potential customers, business objectives and other matters. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its planned platform are set forth in the Company's filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Relations Contact

MJ Clyburn

TraDigital IR



EN
29/01/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Amesite

 PRESS RELEASE

Amesite Accelerates Growth With Launch of AI-Native NurseMagic™ EMR

Amesite Accelerates Growth With Launch of AI-Native NurseMagic™ EMR Company enters the infrastructure layer of post-acute care following sustained revenue expansion and enterprise adoption DETROIT, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST) today announced the launch of the NurseMagic™ EMR, marking a significant expansion of the Company’s platform following a year of strong sequential revenue growth and enterprise traction. The AI-native, modular EMR extends NurseMagic™ from a point-of-care solution into core post-acute care infrastructure, supporting both coexistence...

 PRESS RELEASE

Amesite Announces 69% QoQ Revenue Increase in Q2 2026 and Product Plan...

Amesite Announces 69% QoQ Revenue Increase in Q2 2026 and Product Plans for Coming Months Shareholder Update Reports Positive Customer Reviews, New Segment Growth and Technology Rollouts across Post-Acute Healthcare DETROIT, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading developer of AI-powered enterprise solutions, announces a 69% QoQ increase in revenue even as it reduced its spending. Amesite also reported expanding its customer base and offerings to post-acute health businesses across the U.S. The Company described these results and its pathway to offer the...

 PRESS RELEASE

Amesite Reports 63% Revenue Growth from NurseMagic™ Enterprise; Announ...

Amesite Reports 63% Revenue Growth from NurseMagic™ Enterprise; Announces Launch of AI-Powered Government Form-Fill Automation to Reduce Reporting Burden DETROIT, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading developer of AI-powered enterprise solutions, today announced 63% revenue growth for its NurseMagic™ platform following the launch of its on July 14, 2025. Enterprise sales have now surpassed B2C sales, reflecting rising demand from post-acute care providers seeking scalable, compliant technology designed to deliver full reimbursement rates. Amesite also ...

 PRESS RELEASE

Amesite Launches Census-Based Enterprise Tier for NurseMagic™ to Drive...

Amesite Launches Census-Based Enterprise Tier for NurseMagic™ to Drive Revenue Growth and Meet Enterprise Demand, Significantly Expanding Total Addressable Market New Tier Adds EMR Integration, Team Reporting (IDT) and Custom Form Support — Enabling Scalable Deployment Across Entire Patient Census DETROIT, July 14, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading developer of AI-powered enterprise solutions, today announced the launch of the new NurseMagic™ Enterprise Tier, built to meet the most urgent needs of mid- and large-scale post-acute healthcare providers. Develo...

 PRESS RELEASE

Amesite’s HIPAA Compliant NurseMagic™ App Now Operates in 16 Languages...

Amesite’s HIPAA Compliant NurseMagic™ App Now Operates in 16 Languages — Expanding Access to AI-Powered Charting for Nearly 1 Million U.S. Nurses NurseMagic™ V3.0 uniquely addresses the needs of approximately 20% of U.S. nurses in the U.S. with AI-powered charting in their native language DETROIT, June 25, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading developer of AI-powered enterprise solutions, today announced that its flagship app, NurseMagic™, now supports charting in 16 languages. This major enhancement is designed to address a key barrier to success for nearly 1 ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch